These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3629557)

  • 21. Effect of acetylsalicylic acid on platelet aggregation and thromboxane B2 production in flowing aortic blood in the rat studied with a filter loop technique.
    Martin JF; Suggett AJ; Jones PB; Leach E
    Thromb Res; 1982 Aug; 27(3):251-9. PubMed ID: 6814004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of acetylsalicylic acid in 3 different formulations on in vitro and in vivo platelet function tests. An experimental study on healthy male volunteers.
    Kutti J; Safai-Kutti S; Sigvaldason A; Edgar B; Lundborg P
    Scand J Haematol; 1984 Apr; 32(4):379-84. PubMed ID: 6719042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virgin olive oil polyphenol hydroxytyrosol acetate inhibits in vitro platelet aggregation in human whole blood: comparison with hydroxytyrosol and acetylsalicylic acid.
    Correa JA; López-Villodres JA; Asensi R; Espartero JL; Rodríguez-Gutiérez G; De La Cruz JP
    Br J Nutr; 2009 Apr; 101(8):1157-64. PubMed ID: 18775097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function.
    Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G
    J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of platelet hyperactivity in patients with ischemic cerebrovascular diseases: IV. Determination of the optimal dosage of aspirin by measuring plasma salicylate level.
    Chen YC; Kuo TL; Liu MC; Lien IN; Ang A; Lee TK
    Taiwan Yi Xue Hui Za Zhi; 1987 Sep; 86(9):923-31. PubMed ID: 3694163
    [No Abstract]   [Full Text] [Related]  

  • 26. Resistance to acetylsalicylic acid in patients after ischemic stroke.
    Zytkiewicz M; Giełwanowska L; Wojtasińska E; Psuja P; Zawilska K
    Pol Arch Med Wewn; 2008 Dec; 118(12):727-33. PubMed ID: 19202951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin.
    Gerrard JM; Taback S; Singhroy S; Docherty JC; Kostolansky I; McNicol A; Kobrinsky NL; McKenzie JK; Rowe R
    Circulation; 1989 Jan; 79(1):29-38. PubMed ID: 2910545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of oral administrations to human volunteers of acetylsalicylic acid, sodium salicylate and indomethacin on 12-hydroxyeicosatetraenoic acid formation by stimulated platelets.
    Maderna P; Caruso D; Tremoli E; Galli G
    Thromb Res; 1988 Nov; 52(3):197-206. PubMed ID: 3194896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
    J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of aspirin resistance in persons with previous ischemic stroke.
    Helgason CM; Bolin KM; Hoff JA; Winkler SR; Mangat A; Tortorice KL; Brace LD
    Stroke; 1994 Dec; 25(12):2331-6. PubMed ID: 7974569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ
    Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia.
    Weksler BB; Kent JL; Rudolph D; Scherer PB; Levy DE
    Stroke; 1985; 16(1):5-9. PubMed ID: 3966266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects.
    Tamminen M; Lassila R; Westerbacka J; Vehkavaara S; Yki-Järvinen H
    Int J Obes Relat Metab Disord; 2003 Aug; 27(8):907-11. PubMed ID: 12861231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma".
    Cerletti C; Latini R; Del Maschio A; Galletti F; Dejana E; de Gaetano G
    Thromb Haemost; 1985 Jun; 53(3):415-8. PubMed ID: 4049312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of triflusal and acetylsalicylic acid on platelet aggregation in whole blood of diabetic patients.
    De la Cruz JP; Pavia J; Garcia-Arnes J; Sanchez de la Cuesta F
    Eur J Haematol; 1988 Mar; 40(3):232-6. PubMed ID: 2965654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of low dose aspirin on the platelet function in patients with acute myocardial infarction].
    Jin L; Xu SH; Yan XW
    Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):542-4. PubMed ID: 8269785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro platelets/endothelial cells interactions in presence of acetylsalicylic acid at various dosages.
    Lalanne MC; Ramboer I; de Sèze O; Doutremepuich C
    Thromb Res; 1992 Jan; 65(1):33-43. PubMed ID: 1604441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE).
    Zeymer U; Hohlfeld T; Vom Dahl J; Erbel R; Münzel T; Zahn R; Roitenberg A; Breitenstein S; Pap ÁF; Trenk D
    Thromb Haemost; 2017 Feb; 117(3):625-635. PubMed ID: 28102427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actions and interactions of acetylsalicylic acid, salicylic acid and diflunisal on platelet aggregation.
    Nitelius E; Brantmark B; Fredholm B; Hedner U; Forshell GP; Wåhlin-Boll E; Melander A
    Eur J Clin Pharmacol; 1984; 27(2):165-8. PubMed ID: 6499897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.